Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.17 | -$0.12 | -$0.14 |
| Q2 2026 | 3 | -$0.22 | -$0.15 | -$0.19 |
| Q3 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2026 | 5 | -$0.25 | -$0.15 | -$0.20 |
| Q1 2027 | 1 | -$0.10 | -$0.09 | -$0.10 |
| Q2 2027 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2027 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2027 | 1 | -$0.13 | -$0.12 | -$0.13 |
MDxHealth SA last posted its earnings results on Wednesday, May 13th, 2026. The company reported $-0.19 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.06. The company had revenue of 54.67 M for the quarter and had revenue of 107.88 M for the year. MDxHealth SA has generated $-1 earnings per share over the last year ($-0.67 diluted earnings per share) and currently has a price-to-earnings ratio of -0.74. MDxHealth SA has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 2025 | N/A | -$0.37 | N/A | $30.89 M | $54.67 M |
| 06/30/2025 | Q2 2025 | N/A | -$0.30 | N/A | $26.31 M | $26.61 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.54 | N/A | $23.88 M | $48.06 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.73 | N/A | $20.86 M | $41.99 M |
| 12/31/2023 | Q4 2023 | N/A | -$0.76 | N/A | N/A | $38.75 M |
| 06/30/2023 | Q2 2023 | N/A | -$1.02 | N/A | N/A | $31.45 M |
| 12/31/2022 | Q4 2022 | N/A | -$2.13 | N/A | N/A | $24.05 M |
| 06/30/2022 | Q2 2022 | N/A | -$1.34 | N/A | N/A | $13.01 M |
| 12/31/2021 | Q4 2021 | N/A | -$1.29 | N/A | N/A | $11.51 M |
| 06/30/2021 | Q2 2021 | N/A | -$1.20 | N/A | N/A | $10.73 M |
| 12/31/2020 | Q4 2020 | -$1.50 | -$1.66 | -0.16 | N/A | $8.58 M |
| 06/30/2020 | Q2 2020 | N/A | -$1.80 | N/A | N/A | $9.88 M |
| 12/31/2019 | Q4 2019 | N/A | -$4.38 | N/A | N/A | $912.00 K |
| 06/30/2019 | Q2 2019 | N/A | -$2.40 | N/A | N/A | $10.87 M |
| 12/31/2018 | Q4 2018 | N/A | -$2.92 | N/A | N/A | $11.20 M |
| 06/30/2018 | Q2 2018 | N/A | -$2.70 | N/A | N/A | $17.20 M |
| 12/31/2017 | Q4 2017 | N/A | -$2.60 | N/A | N/A | $16.25 M |
| 06/30/2017 | Q2 2017 | N/A | $0.10 | N/A | N/A | $24.26 M |
| 12/31/2016 | Q4 2016 | N/A | -$1.20 | N/A | N/A | $17.03 M |
| 06/30/2016 | Q2 2016 | N/A | -$1.70 | N/A | N/A | $12.95 M |
The conference call for MDxHealth SA's latest earnings report can be listened to online.
The conference call transcript for MDxHealth SA's latest earnings report can be read online.
MDxHealth SA (:MDXH) has a recorded annual revenue of $107.88 M.
MDxHealth SA (:MDXH) has a recorded net income of $-33,519,000.MDxHealth SA has generated $-0.67 earnings per share over the last four quarters.
MDxHealth SA (:MDXH) has a price-to-earnings ratio of -0.74 and price/earnings-to-growth ratio is -0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED